Questions answered
CJC-1295 Ipamorelin FAQ
Direct answers, drawn from the published record, with the citation behind every number.
What is CJC-1295 / Ipamorelin good for?
In studies of its single components it raises growth hormone and IGF-1: one subcutaneous dose of CJC-1295 with DAC lifted mean plasma GH two- to ten-fold for six or more days and IGF-1 1.5- to three-fold for nine to eleven days in healthy adults, with IGF-1 above baseline up to 28 days after repeat dosing [1]. Downstream body-composition, recovery, and sleep effects are reported anecdotally or extrapolated, not proven for the blend.
What is CJC-1295 / Ipamorelin?
It is a research combination of two lab-made peptides. CJC-1295 is a long-acting analogue of GHRH, the natural signal that tells the pituitary to release growth hormone [1]. Ipamorelin is a selective GH secretagogue that acts on the separate ghrelin receptor [2]. Together they are a growth-hormone-secretagogue "stack" — neither is FDA-approved, and the fixed blend has never been tested in a controlled trial.
Is CJC-1295 the same as Ipamorelin?
No. They are different molecules acting on different receptors. CJC-1295 is a GHRH analogue working through the GHRH receptor and the cAMP pathway; ipamorelin is a pentapeptide working through the ghrelin receptor (GHS-R1a) and the calcium pathway [2][5]. They are combined precisely because they are different — two independent triggers produce more GH together than either alone [3].
Does CJC-1295 / Ipamorelin work?
For raising GH and IGF-1, the single-component evidence is clear: CJC-1295 with DAC produced a two- to ten-fold GH rise for six or more days and a sustained IGF-1 rise in healthy adults [1]. For the downstream effects people actually want — fat loss, muscle, recovery — there is no controlled trial of the fixed CJC-1295 Ipamorelin blend, so those rest on extrapolation and anecdote.
What are the bad side effects of CJC-1295 and Ipamorelin?
The class's chief metabolic concern is higher blood glucose from reduced insulin sensitivity [6]. GH-excess effects — fluid retention, puffiness, carpal-tunnel-type tingling, joint aches — are mechanistically expected [6]. Notably, ipamorelin itself is selective: it did not raise ACTH or cortisol even at doses over 200 times the GH-effective amount [2]. Community reports add injection-site reactions and brief post-dose flushing.
How long do CJC-1295 and Ipamorelin take to work?
Biochemically, fast: a single CJC-1295 (DAC) dose raised GH two- to ten-fold for six or more days and IGF-1 for nine to eleven days, with multi-dose IGF-1 elevation lasting up to 28 days [1]. Ipamorelin's GH pulse peaks around 40 minutes post-dose. Any reported feel-it effects (sleep, recovery) are described over the first one to several weeks and are anecdotal, not clinical.
How many mg of CJC-1295 and Ipamorelin should I take?
This site does not provide human dosing. The literature records research doses only: CJC-1295 with DAC was studied subcutaneously at 30–90 µg/kg in early human pharmacokinetic work [1], and ipamorelin's doses come mostly from rodent studies. No validated human protocol exists for the fixed blend, and nothing here should be read as a regimen to follow.
Does CJC-1295 raise testosterone?
CJC-1295 acts on the growth-hormone axis, not the testosterone axis. Its documented effect is a sustained rise in GH and IGF-1 [1]; the published record does not establish a direct increase in testosterone. Claims that it raises testosterone are not supported by the CJC-1295 pharmacology literature summarized here.
Does Ipamorelin reduce belly fat?
There is no controlled trial of ipamorelin or the blend for belly fat. The closest high-quality evidence is for a different GHRH analogue: a 2026 meta-analysis of tesamorelin found a significant reduction in visceral (belly) fat (mean difference −27.71 cm²) and hepatic fat, with increased lean mass [8]. That is read-across context for the GH/IGF-1 mechanism, not proof for ipamorelin.
What are the downsides to CJC-1295 / Ipamorelin?
Beyond glucose elevation and GH-excess fluid effects [6][2], the largest downside is evidentiary: the fixed blend has never been studied in a controlled human trial, so its long-term safety is unknown. Research-grade peptide from unregulated suppliers has unverified identity, purity, and sterility, and subcutaneous self-administration has no published safety characterization. Both compounds are also WADA-prohibited under Section S2.
Which is better, Sermorelin or Ipamorelin?
They are complements, not competitors. Sermorelin is a GHRH analogue acting on the GHRH receptor — the same receptor as CJC-1295 — while ipamorelin acts on the ghrelin receptor [2]. "Better" depends on the goal: a GHRH analogue and a GHRP are typically combined because their independent pathways act synergistically [3], which is why CJC-1295 (a GHRH analogue) is paired with ipamorelin (a GHRP).
Can you take both Sermorelin and Ipamorelin together?
The mechanistic rationale for a GHRH-plus-GHRP combination is well established: in normal men, submaximal GH-releasing-peptide doses combined with GHRH stimulated GH release synergistically, the two acting through independent mechanisms [3]. That said, no controlled human trial validates a sermorelin-plus-ipamorelin protocol specifically, and this site provides no dosing guidance for any combination.
Is Tesamorelin better than Ipamorelin?
They are different classes with different evidence. Tesamorelin is a GHRH analogue with strong randomized-trial data for visceral-fat reduction — a 2026 meta-analysis showed significant cuts in visceral and hepatic fat and gains in lean mass [8]. Ipamorelin is a selective GHRP with mostly preclinical efficacy data [2]. No head-to-head trial compares them, so "better" depends entirely on the endpoint.
Is Ipamorelin stronger than Sermorelin?
They act through different receptors, so "stronger" is not a clean comparison. Ipamorelin is a selective ghrelin-receptor secretagogue that matched the GH efficacy of GHRP-6 in swine without raising stress hormones [2]; sermorelin is a GHRH-receptor analogue. Because their pathways are independent and synergistic [3][5], they are usually combined rather than ranked against each other.
Which is safer, Sermorelin or Ipamorelin?
Neither has a long-term human safety database, and no trial compares them directly. Ipamorelin's notable safety feature is selectivity — it released GH without raising ACTH or cortisol even at doses over 200 times the GH-effective amount [2]. Across the whole secretagogue class, the consistent safety signal is increased blood glucose from reduced insulin sensitivity, with long-term cancer-and-mortality data still needed [6].
How much CJC-1295 / Ipamorelin should I take?
No human dose is provided here. The record holds research doses only — CJC-1295 with DAC studied subcutaneously at 30–90 µg/kg in early human pharmacokinetics [1], ipamorelin largely from rodent work — and there is no validated human protocol for the fixed combination. This page describes what was studied, not what anyone should do.
Is CJC-1295 / Ipamorelin safe?
There is no controlled human trial of the fixed blend, so its safety is formally uncharacterized. The broad secretagogue review found the class generally well tolerated short-term, with increased blood glucose as the chief concern and long-term cancer and mortality data still lacking [6]. Ipamorelin's selectivity is reassuring [2], but unverified research-grade purity and self-administration add risks outside any studied protocol.
Is Ipamorelin FDA approved?
No. Ipamorelin is not approved by the FDA for any human indication, nor is CJC-1295; both are sold only as research chemicals. A class review notes GH secretagogues are well tolerated overall, with increased blood glucose the chief safety concern and long-term cancer and mortality data still needed [6]. The fixed combination has never been studied in a controlled human trial.
How to reconstitute CJC-1295 / Ipamorelin (5mg)?
This site does not provide preparation instructions. As laboratory-handling context only: lyophilised (freeze-dried) research peptide is typically reconstituted with bacteriostatic water — sterile water containing 0.9% benzyl alcohol as a preservative — then kept refrigerated at 2–8 °C, with agitation and repeated freeze-thaw avoided, since aqueous solutions degrade over weeks. This is descriptive context, not a procedure to follow.
Where to inject CJC-1295 / Ipamorelin?
This site provides no administration instructions. The routes recorded in the research literature are subcutaneous and intravenous, with continuous subcutaneous infusion and intranasal routes used in some rodent pharmacokinetic studies. Those are descriptions of how studies were conducted, not guidance for human use.
Does Ipamorelin make you hungry / increase appetite?
Plausibly yes, by mechanism: ipamorelin acts on the ghrelin receptor, and ghrelin is the body's hunger signal, so increased appetite after dosing is among the most consistently reported community effects. It is generally described as milder than with older GH-releasing peptides like GHRP-6. The broader secretagogue safety profile is otherwise dominated by the glucose signal [6].
Can I take CJC-1295 / Ipamorelin in the morning?
This site offers no timing instructions. Research context: CJC-1295 with DAC has a multi-day half-life, so its exposure is not tied to time of day [1], whereas ipamorelin produces a short pulse peaking around 40 minutes. Community write-ups often favor pre-bed dosing to align with growth hormone's natural nighttime rhythm, but that is anecdotal preference, not validated protocol.